Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Allergy and Immunology (Phase 4)
Alzheimer Disease (Phase 4)
Asthma (Phase 1/Phase 2)
Blood Pressure (Early Phase 1)
Breast Neoplasms (Phase 3)
Carotid Stenosis (Phase 3)
Cerebrovascular Disorders (Phase 4)
Cognition (Early Phase 1)
Cognition Disorders (Phase 4)
Cognitive Dysfunction (Phase 4)
Coronary Artery Disease (Phase 4)
Dementia (Phase 3)
Dementia, Vascular (Phase 4)
Depression (Phase 1)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Retinopathy (Phase 1)
Fetal Growth Retardation (Phase 2)
Glaucoma (Phase 3)
Glaucoma, Open-Angle (Phase 2)
Healthy Volunteers (Phase 4)
Hearing Loss (Phase 2)
HIV Infections (Phase 1)
Intermittent Claudication (Phase 1/Phase 2)
Memory Disorders (Phase 3)
Memory, Short-Term (Phase 1/Phase 2)
Multiple Sclerosis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Ototoxicity (Phase 2)
Peripheral Vascular Diseases (Phase 1/Phase 2)
Raynaud Disease (Phase 2)
Retinitis Pigmentosa (Early Phase 1)
Sexual Dysfunctions, Psychological (Phase 2)
Tinea Pedis (Phase 1)
Vestibular Neuronitis (Phase 3)
Vitiligo (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
